Peripheral Vascular Devices – Market Insights – Europe

The European PV device market will see increasing penetration of endovascular techniques and increasing uptake of premium-priced products such as drug-eluting technologies and IVL, as well as a particular focus on procedures treating iliac and lower-limb arteries. Nevertheless, price competition, unfavorable reimbursement, and unwillingness to some clinicians to adopt new technologies will limit revenue growth to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in Europe from 2019 through 2033.

Uptake of premium-priced devices will drive growth in the market.

To what degree will DES and DCBs be adopted in Europe over the forecast period?

What is the future outlook for the adoption of covered stents?

How readily have IVL procedures been adopted for PV indications?

What impact will these trends have on the competitive landscape?

Recently published positions and guidelines from key organizations are expected to impact over the adoption of paclitaxel-eluting devices.

How will the recent FDA letter concerning paclitaxel-based devices affect device choice in Europe?

Will the recently MHRA published guidelines have a positive impact in the UK? And in other European countries?

What is the current position about paclitaxel-eluting device among physicians?

How will these updates affect to other alternative drug-eluting devices in the market?

Procedure volume growth will be supported by increasing interventional endovascular techniques in iliac, fem-pop and infrapop indications.

Which devices are expected to see the greatest uptake in these indications??

How has this focus impacted the PV device market?

M&A activities or partnerships involving key competitors may lead to shifts in market shares going forward.

Which acquisitions have occurred, and how will these acquisitions impact competitor performance in the future?

How are competitors leveraging product portfolio acquisitions to expand their product offerings?